Paper16622207
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
Walther M and 18 others. Infect Immun, 2006. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein. Papers, record 16622207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16622207
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria Vaccines | Major topic |
| Plasmodium falciparum | Major topic |
| Protozoan Proteins | Major topic |
| Vaccines, Synthetic | Major topic |
| Adult | |
| Animals | |
| Antibodies, Protozoan | |
| Clinical Trials as Topic | |
| Glycosylphosphatidylinositols | |
| Humans | |
| Immunization, Secondary | |
| Interferon-gamma | |
| Parasitemia | |
| Poxviridae | |
| Vaccinia virus |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G84/6323 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15315836 | Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif. | Vaccine | 2004 | https://conductscience.org/library/papers/15315836 | PubMed |
| 2 | 1703674 | Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. | Trans R Soc Trop Med Hyg | 1990 | https://conductscience.org/library/papers/1703674 | PubMed |
| 3 | 15655787 | Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15655787 | PubMed |
| 4 | 16014857 | Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials. | Am J Trop Med Hyg | 2005 | https://conductscience.org/library/papers/16014857 | PubMed |
| 5 | 9862371 | Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. | Eur J Immunol | 1998 | https://conductscience.org/library/papers/9862371 | PubMed |
| 6 | 14978115 | Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. | J Immunol | 2004 | https://conductscience.org/library/papers/14978115 | PubMed |
| 7 | 808142 | Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. | Am J Trop Med Hyg | 1975 | https://conductscience.org/library/papers/808142 | PubMed |
| 8 | 15865223 | Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption. | Antivir Ther | 2005 | https://conductscience.org/library/papers/15865223 | PubMed |
| 9 | 11747915 | Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. | Lancet | 2001 | https://conductscience.org/library/papers/11747915 | PubMed |
| 10 | 12766765 | Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. | Nat Med | 2003 | https://conductscience.org/library/papers/12766765 | PubMed |
| 11 | 11183752 | Malaria. A renewed assault on an old and deadly foe. | Science | 2000 | https://conductscience.org/library/papers/11183752 | PubMed |
| 12 | 6057225 | Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. | Nature | 1967 | https://conductscience.org/library/papers/6057225 | PubMed |
| 13 | 14604567 | Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals. | Vaccine | 2003 | https://conductscience.org/library/papers/14604567 | PubMed |
| 14 | 11241272 | Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection. | Eur J Immunol | 2001 | https://conductscience.org/library/papers/11241272 | PubMed |
| 15 | 15361247 | Does malaria suffer from lack of memory? | Immunol Rev | 2004 | https://conductscience.org/library/papers/15361247 | PubMed |
| 16 | 15034567 | A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. | Nat Med | 2004 | https://conductscience.org/library/papers/15034567 | PubMed |
| 17 | 11803063 | Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. | Vaccine | 2002 | https://conductscience.org/library/papers/11803063 | PubMed |
| 18 | 2464643 | Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. | J Immunol | 1989 | https://conductscience.org/library/papers/2464643 | PubMed |
| 19 | 11393868 | Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. | Science | 2001 | https://conductscience.org/library/papers/11393868 | PubMed |
| 20 | 16488059 | Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. | Vaccine | 2006 | https://conductscience.org/library/papers/16488059 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34930178 | Reproducibility of malaria sporozoite challenge model in humans for evaluating efficacy of vaccines and drugs: a systematic review. | BMC Infect Dis | 2021 | https://conductscience.org/library/papers/34930178 | PubMed |
| 29083948 | Chimpanzee adenoviral vectors as vaccines for outbreak pathogens. | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/29083948 | PubMed |
| 28923897 | Controlled Human Malaria Infection: Applications, Advances, and Challenges. | Infect Immun | 2018 | https://conductscience.org/library/papers/28923897 | PubMed |
| 26511884 | Recombinant modified vaccinia virus Ankara-based malaria vaccines. | Expert Rev Vaccines | 2016 | https://conductscience.org/library/papers/26511884 | PubMed |
| 25853483 | The evolution of poxvirus vaccines. | Viruses | 2015 | https://conductscience.org/library/papers/25853483 | PubMed |
| 25522180 | A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS. | PLoS One | 2014 | https://conductscience.org/library/papers/25522180 | PubMed |
| 25336730 | Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals. | J Infect Dis | 2015 | https://conductscience.org/library/papers/25336730 | PubMed |
| 25140889 | 4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques. | PLoS One | 2014 | https://conductscience.org/library/papers/25140889 | PubMed |
| 24575238 | Induction of an Antibody Response against Plasmodium falciparum F2RIIEBA by Heterologous Prime-boost Immunisation. | Trop Life Sci Res | 2013 | https://conductscience.org/library/papers/24575238 | PubMed |
| 23733037 | Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23733037 | PubMed |
| 23710439 | Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23710439 | PubMed |
| 23583893 | Reflections on the early development of poxvirus vectors. | Vaccine | 2013 | https://conductscience.org/library/papers/23583893 | PubMed |
| 22701640 | Comparison of clinical and parasitological data from controlled human malaria infection trials. | PLoS One | 2012 | https://conductscience.org/library/papers/22701640 | PubMed |
| 22403305 | Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials. | Am J Trop Med Hyg | 2012 | https://conductscience.org/library/papers/22403305 | PubMed |
| 22363582 | Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. | PLoS One | 2012 | https://conductscience.org/library/papers/22363582 | PubMed |
| 22348325 | Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice. | Malar J | 2012 | https://conductscience.org/library/papers/22348325 | PubMed |
| 22230255 | A review of malaria vaccine clinical projects based on the WHO rainbow table. | Malar J | 2012 | https://conductscience.org/library/papers/22230255 | PubMed |
| 21603645 | Dual neonate vaccine platform against HIV-1 and M. tuberculosis. | PLoS One | 2011 | https://conductscience.org/library/papers/21603645 | PubMed |
| 21179119 | Experimental human challenge infections can accelerate clinical malaria vaccine development. | Nat Rev Immunol | 2011 | https://conductscience.org/library/papers/21179119 | PubMed |
| 21123952 | Advances and challenges in malaria vaccine development. | J Clin Invest | 2010 | https://conductscience.org/library/papers/21123952 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16622207
GET https://conductscience.org/api/papers/v1/16622207/references?page=2